The MphaR team was pretty busy in June. There were a lot of important clinical trials summits requiring attending.  We really missed seeing our colleagues F2F, so we readily took the opportunity to join the ASCO Summit in Chicago and the EHA event in Vienna. 

The American Society of Clinical Oncology 2022 Annual Meeting took place on 3-7 June. Natalia Denisova, PhD, Head of Medical Affairs, Sara Frau, PhD, Scientific Director Oncology and Stacey She, Project Lead US, were looking forward to representing MphaR there. 

During this event, our team had a great opportunity to get and share knowledge in the area of oncology clinical trials and innovative therapies. 

The ASCO Summit allowed the MphaR team to meet and collaborate with many scientists and companies who aim to participate and develop the innovative therapies and improve the outcome of cancer patients.

The MphaR team attended European Hematology Association 2022 Congress in Vienna on 9-12 June. The event was organized in hybrid format and it represented great implementation of modern virtual technologies into the clinical trials industry. 

Our team consisted of Natalia Denisova, PhD, Head of Medical Affairs, Sara Frau, PhD, Scientific Director Oncology and Marie Almeida, Medical Writer, who aimed to represent MphaR in the area of hematology. 

We really appreciated the opportunity to see our colleagues & hematologists in person after 2 years break! EHA was celebrating 30 years, we enjoyed the meetings, discussions, and seeing the updates from key trials.

MphaR was pleased to be part of such interesting and productive summits. We hope to develop established connections and collaborate in the future. Our team is looking forward to participating in further events.

‍